CME Enterprise
Overview
Company
Team
Medical Team
Learning Organization
Professionalism and Recognition
Awards and Distinctions
Boards and Committees
Memberships and Affiliations
Speaking Engagements and Publications
ACCME Educators and Site Surveyors
Culture
Career Opportunities
Contact Us

 

About Us
Speaking Engagements and Publications

Listed below are speaking engagements, publications, and conducted studies for select CME Enterprise team members.


Bruce J. Bellande, PhD, FACME

President

Selected Technical Reports and Studies
  • “A Mississippi State-Based Program to Plan, Coordinate, and Implement Training Opportunities for Long-Term Care Provider Personnel”
  • “Services Provided by the Division of Special Activities [now Division of Continuing Education], 1971-1972 through 1975-1976 and Projections for Future Service Activities” (a report prepared for the University’s Self-Study submitted to the Southern Association of Colleges and Schools)
  • “A Feasibility Study: Continuing Education for Mississippi’s Health Care Team”
  • “Focus on Scientific and Clinical Symposia,” 1993 and 1994 Digests (Editor)
  • “Physician Profiling & Behavior Change,” 1998-Present (Editorial Advisory Board)
  • “The Almanac” (Alliance for Continuing Medical Education monthly newsletter) – Managing Editor

Speaking Engagements
  • Accreditation Council for Continuing Medical Education
    “Understanding ACCME Accreditation Workshops Faculty, 1993-2007”
  • Alliance for Continuing Medical Education Annual Conferences Faculty, 1990-2007, Program Chair, 1997
  • Institutes: 1998-2006 Spring Institutes "CME: The Basics"
  • CME Leadership in the 21st Century Faculty for “A Case-Based Conference for Current and Future Leaders in CME” September 2002 and October 2003
    Duke University, School of Medicine, Durham, North Carolina
  • Ohio State Medical Association
    June 2004 and August 2006 CME Symposium, Columbus, Ohio
    (Keynote Speaker both years)
    "New Standards for Commercial Support"
    "Best Practices in Accreditation"
  • 5th and 6th Annual Forum on CME
    June 2006 and 2007, Philadelphia, Pennsylvania
    (Keynote Speaker both years)
    "Good to Great: Lessons for CME Transition"
    "Reforming CME: A Call to Action for the Health Care Community"
  • Global Alliance for Medical Education
    11th Annual Meeting, June 2006, Rome, Italy
    "Pathways to Quality CME: Maintenance of Competence for CME Professionals"
  • Medical Education Congress
    May 2005 and 2006, Philadelphia, Pennsylvania
    "An Overview of the CME Landscape to Plan Your Communication Strategies Effectively"
    "New Methods for CME Accreditation: Maintenance of Certification for Physician Self-Assessment and Quality Improvement"
  • 3rd Annual Medical Education Forum
    December 2005, Philadelphia, Pennsylvania
    "CME Best Practices and Compliance Fundamentals for Pharma Grants Making" and "Late-Breaking Developments in CME"
  • Jefferson Medical College
    Leadership Symposium
    November 2006, Philadelphia, Pennsylvania
    "Medical Education in the 21st Century"
  • American College of Surgeons
    Leadership Conference
    June 2005, Washington, DC
    "Accomplishing Your CME Mission"
  • American Association of Hospital Education
    Fall Educational Institute
    November 2004, Boston, Massachusetts
    "Results of the Conjoint Committee on CME and the Competency -Based Continuum of Medical Education"
  • American Medical Association Town Meeting
    June 2005, Chicago, Illinois
    "Pathways to Maintenance of Competence for CME Professionals"
  • National Medical Association
    Spring Leadership Conference
    November 2005, Washington, DC
    "Valuable, Effective and Compliant CME: Pathways to Success"
  • Pharmaceutical Alliance for CME Forum
    "CME Provider/Industry Collaboration in the New Reality"
    November 2004, Nutley, New Jersey
  • CME Summits
    November 2004-2007
    "Reforming and Repositioning CME: The CME Professional's Perspective"
    "Performance Improvement in Practice"
    “Defining Physician Self-Assessment”


Anthony Choi, PhD

Medical Writer

Peer-reviewed journal publications (Selection out of 36)
  • Smiley KL, McNeal MM, Basu M, Choi AH, Clements JD, Ward RL. Association of gamma interferon and interleukin-17 production in intestinal CD4+ T cells with protection against rotavirus shedding in mice intranasally immunized with VP6 and the adjuvant LT(R192G). J Virol. 2007;81(8):3740-3748.
  • McNeal MM, Basu M, Bean JA, et al. Intrarectal immunization of mice with VP6 and either LT(R192G) or CTA1-DD as adjuvant protects against fecal rotavirus shedding after EDIM challenge. Vaccine. 2007;25(33):6224-6231.
  • McNeal MM, Basu M, Bean JA, Clements JD, Choi AH, Ward RL. Identification of an immunodominant CD4+ T cell epitope in the VP6 protein of rotavirus following intranasal immunization of BALB/c mice. Virology. 2007;363(2):410-418.
  • Choi AH, Smiley K, Basu M, et al. Protection of mice against rotavirus challenge following intradermal DNA immunization by Biojector needle-free injection. Vaccine. 2007;25(16):3215-3218.
  • VanCott JL, Prada AE, McNeal MM, et al. Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidates. J Virol. 2006;80(10):4949-4961.
  • McNeal MM, Stone SC, Basu M, et al. Protection against rotavirus shedding after intranasal immunization of mice with a chimeric VP6 protein does not require intestinal IgA. Virology. 2006;346(2):338-347.
  • Zhao W, Xia M, Bridges-Malveo T, et al. Evaluation of rotavirus dsRNA load in specimens and body fluids from experimentally infected juvenile macaques by real-time PCR. Virology. 2005;341(2):248-256.
  • McNeal MM, Sestak K, Choi AH, et al. Development of a rotavirus-shedding model in rhesus macaques, using a homologous wild-type rotavirus of a new P genotype. J Virol. 2005;79(2):944-954.
  • Choi AH, Smiley K, Basu M. Induction of immune responses and partial protection in mice after skin immunization with rotavirus VP6 protein and the adjuvant LT(R192G). Vaccine. 2005;23(17-18):2290-2293.
  • Sestak K, McNeal MM, Choi A, et al. Defining T-cell-mediated immune responses in rotavirus-infected juvenile rhesus macaques. J Virol. 2004;78(19):10258-10264.
  • McNeal MM, Belli J, Basu M, Choi AH, Ward RL. Discovery of a new strain of murine rotavirus that is consistently shed in large quantities after oral inoculation of adult mice. Virology. 2004;320(1):1-11.
  • Choi AH, Basu M, McNeal MM, Bean JA, Clements JD, Ward RL. Intranasal administration of an Escherichia coli-expressed codon-optimized rotavirus VP6 protein induces protection in mice. Protein Expr Purif. 2004;38(2):205-216.
  • Vancott JL, McNeal MM, Choi AH, Ward RL. The role of interferons in rotavirus infections and protection. J Interferon Cytokine Res. 2003;23(3):163-170.
  • Choi AH, McNeal MM, Basu M, et al. Functional mapping of protective epitopes within the rotavirus VP6 protein in mice belonging to different haplotypes. Vaccine. 2003;21(7-8):761-767.


Richard Thielen, PhD

Medical Education Content Specialist

Addresses and Invited Presentations
  • "Housing conditions alter GABAA receptor properties in P and NP rats"
    Presented at The Annual Meeting of the Research Society on Alcoholism, June 1992
  • "GABAergic Systems in Lines of Rats Selectively Bred for Disparate Alcohol-seeking Behavior"
    Presented at: The University of Southern California School of Pharmacy, Department of Molecular Pharmacology and Toxicology - February 1993; Northwestern University Medical School, Department of Molecular Pharmacology - March 1993
  • "In Vivo Characterization of Two New 5-HT1A Receptor Antagonists: p-MPPI and p-MPPF"
    Presented to: Ergo Science Corporation, Charlestown MA - January 1997; Eli Lilly and Company, Indianapolis, IN - October 1998
  • "Chronic consumption of multiple ethanol concentrations alters basal serotonin (5-HT) levels in the nucleus accumbens (Acb)"
    Presented at: The Annual Meeting of the Society for Neuroscience, October 2002
  • "Chronic Alcohol Drinking Alters 5-HT3 Receptors Regulating the Mesolimbic Dopamine System"
    Presented at: The Annual Meeting of the Research Society on Alcoholism, June 2003

Publications: Chapters and Reviews
  • Schweizer, E., Thielen, R.J. and Frazer, A. (1997) Venlafaxine: a novel antidepressant compound. Expert Opinion on Investigational Drugs 6:65-78.

Publications: Papers and Manuscripts
  • Engleman, E.A., Ingraham, C.M., Franklin, K.M., Keith, C.M., McClaren, J.A., Schultz, J.A., Morzorati, S.L., O’Connor, S., Thielen, R.J., Murphy, J.M. and McBride, W.J. (2008) In vivo time-course changes in ethanol levels sampled with subcutaneous microdialysis. Alcohol. Clin Exp. Res. 32:435-442.
  • Liu, W., Thielen, R.J., Rodd, Z.A. and McBride W.J. (2007) Activation of serotonin-3 receptors increases dopamine release within the ventral tegmental area of Wistar and alcohol-preferring (P) rats. Alcohol. 40:167-176.
  • Liu, W.; Thielen, R.J. and McBride, W.J. (2006) Effects of repeated daily treatments with a 5-HT3 receptor antagonist on functional activity of 5-HT3 receptors within the nucleus accumbens and ventral tegmental area of Wistar rats. Pharmacol. Biochem. Behav. 84:370-377.
  • Sahr, A.E., Thielen, R.J., Lumeng, L., Li, T.-K. and McBride, W.J. (2004) Long-lasting alterations of the mesolimibic dopamine system following periadolescent ethanol drinking by alcohol-preferring (P) rats. Alcohol. Clin. Exp. Res. 28:702-711.
  • McBride, W.J., Lovinger, D.M., Machu, T., Thielen, R.J., Rodd, Z.A., Murphy, J.M., Roache, J.D. and Johnson, B.A. (2004) Serotonin-3 receptors in the actions of alcohol, alcohol reinforcement and alcoholism. Alcohol. Clin. Exp. Res. 28:257-267.
  • Thielen R.J., Engleman, E.A., Rodd, Z.A., Murphy, J.M., Lumeng, L., Li, T.-K., and McBride, W.J. (2004) Ethanol drinking and deprivation alter dopaminergic and serotonergic function in the nucleus accumbens of alcohol-preferring (P) rats. J. Pharmacol. Exp. Ther. 309:216-225.
  • Thielen R.J., Bare, D.J., McBride, W.J., Lumeng, L. and Li, T.-K. (2002) Ethanol-stimulated serotonin release in the ventral hippocampus: an absence of rapid tolerance for the alcohol-preferring P rat and insensitivity in the alcohol-nonpreferring NP rat. Pharmacol. Biochem. Behav. 71:111-117
  • Thielen, R.J., Morzorati, S.L and McBride, W.J. (2001) Effects of ethanol on the dorsal raphe nucleus and its projections to the caudate putamen. Alcohol. 23:131-139.
  • Bowers, B.J., Henry, M.B., Thielen, R.J., McBride, W.J. (2000) Serotonin 5 HT2 receptor stimulation of dopamine release in the posterior but not anterior nucleus accumbens of the rat. J. Neurochem. 75:1625-1633.
  • Thielen, R.J., McBride, W.J., Lumeng, L. and Li, T.-K. (1998) GABAA receptor function in the cerebral cortex of alcohol-naïve P and NP rats. Pharmacol. Biochem. Behav. 59:209-214.
  • Thielen, R.J., McBride, W.J., Chernet, E., Lumeng, L. and Li, T.-K. (1997) Regional densities of benzodiazepine sites in the CNS of alcohol-naive P and NP rats. Pharmacol. Biochem. Behav. 57:875-882.
  • Thielen, R.J., Fangon, N.B. and Frazer, A. (1996) 4 (2' Methoxyphenyl)-1-[2'-[N-(2"-pyridinyl)-p-iodobenzamido]ethyl] piperazine and 4 (2' methoxyphenyl)-1-[2'-[N-(2"-pyridinyl)-p fluorobenzamido]ethyl]piperazine, two new antagonists at pre- and postsynaptic serotonin-1A receptors. J. Pharmacol. Exp. Ther. 277:661-670.
  • Thielen, R.J. and Frazer, A. (1995) Effects of novel 5-HT1A receptor antagonists on measures of post-synaptic 5-HT1A receptor activation in vivo. Life Sci. 56:PL163-PL168.
  • Thielen, R.J., McBride, W.J., Lumeng, L. and Li, T.-K. (1993) Housing conditions alter GABAA receptor of alcohol-preferring and –nonpreferring rats. Pharmacol. Biochem. Behav. 46:723-727.